Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rein Therapeutics (RNTX) Goodwill & Intangibles (2023 - 2025)

Rein Therapeutics (RNTX) has disclosed Goodwill & Intangibles for 3 consecutive years, with $19.8 million as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles fell 59.14% to $19.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.8 million through Dec 2025, down 59.14% year-over-year, with the annual reading at $19.8 million for FY2025, 59.14% down from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $19.8 million at Rein Therapeutics, down from $48.5 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $85.5 million in Q4 2023, with the low at $19.8 million in Q4 2025.
  • Average Goodwill & Intangibles over 3 years is $61.8 million, with a median of $48.5 million recorded in 2024.
  • The sharpest move saw Goodwill & Intangibles plummeted 43.26% in 2024, then crashed 59.14% in 2025.
  • Over 3 years, Goodwill & Intangibles stood at $85.5 million in 2023, then tumbled by 43.26% to $48.5 million in 2024, then plummeted by 59.14% to $19.8 million in 2025.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods came in at $19.8 million, $48.5 million, and $48.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.